Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
1.35
CAD
Market Closed
Market Cap:
CA$15.4m
Relative Value
There is not enough data to reliably calculate the relative value of MRV.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MRV
Relative Value
Base Case
Not Available
Multiples Across Competitors
MRV Competitors Multiples
Nuvo Pharmaceuticals Inc Competitors
Nuvo Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
15.4m CAD | 0.2 | 1 | 3.6 | 5.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
990.8B USD | 15.2 | 48 | 32.3 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.6B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
285.8B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.4B GBP | 5.4 | 31 | 17.1 | 24.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
238.6B CHF | 5.4 | 22 | 13.5 | 17.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.5 | 9.9 | 11.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.2B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 6.8 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
